Logo image of MBCN

MIDDLEFIELD BANC CORP (MBCN) Stock Fundamental Analysis

NASDAQ:MBCN - Nasdaq - US5963042040 - Common Stock - Currency: USD

29.28  -0.57 (-1.91%)

After market: 29.28 0 (0%)

Fundamental Rating

3

MBCN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 395 industry peers in the Banks industry. MBCN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MBCN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MBCN was profitable.
MBCN had a positive operating cash flow in the past year.
Each year in the past 5 years MBCN has been profitable.
MBCN had a positive operating cash flow in each of the past 5 years.
MBCN Yearly Net Income VS EBIT VS OCF VS FCFMBCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

MBCN has a Return On Assets of 0.84%. This is comparable to the rest of the industry: MBCN outperforms 51.89% of its industry peers.
MBCN has a Return On Equity of 7.37%. This is comparable to the rest of the industry: MBCN outperforms 41.81% of its industry peers.
Industry RankSector Rank
ROA 0.84%
ROE 7.37%
ROIC N/A
ROA(3y)0.91%
ROA(5y)0.94%
ROE(3y)7.91%
ROE(5y)8.47%
ROIC(3y)N/A
ROIC(5y)N/A
MBCN Yearly ROA, ROE, ROICMBCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

MBCN's Profit Margin of 22.86% is in line compared to the rest of the industry. MBCN outperforms 47.10% of its industry peers.
MBCN's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for MBCN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 22.86%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.08%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
MBCN Yearly Profit, Operating, Gross MarginsMBCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

MBCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MBCN has been reduced compared to 1 year ago.
The number of shares outstanding for MBCN has been increased compared to 5 years ago.
MBCN has a better debt/assets ratio than last year.
MBCN Yearly Shares OutstandingMBCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MBCN Yearly Total Debt VS Total AssetsMBCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of MBCN is 0.70, which is an excellent value as it means it would take MBCN, only 0.70 years of fcf income to pay off all of its debts.
MBCN's Debt to FCF ratio of 0.70 is fine compared to the rest of the industry. MBCN outperforms 79.09% of its industry peers.
MBCN has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MBCN (0.06) is better than 80.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.7
Altman-Z N/A
ROIC/WACCN/A
WACC14.05%
MBCN Yearly LT Debt VS Equity VS FCFMBCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MBCN Yearly Current Assets VS Current LiabilitesMBCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

The earnings per share for MBCN have decreased by -5.12% in the last year.
The Earnings Per Share has been growing slightly by 1.06% on average over the past years.
The Revenue has decreased by -5.57% in the past year.
The Revenue has been growing slightly by 7.99% on average over the past years.
EPS 1Y (TTM)-5.12%
EPS 3Y-12.16%
EPS 5Y1.06%
EPS Q2Q%36.36%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y7.02%
Revenue growth 5Y7.99%
Sales Q2Q%2.89%

3.2 Future

MBCN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.13% yearly.
MBCN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.83% yearly.
EPS Next Y-3.12%
EPS Next 2Y2.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.67%
Revenue Next 2Y6.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MBCN Yearly Revenue VS EstimatesMBCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
MBCN Yearly EPS VS EstimatesMBCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.35, MBCN is valued correctly.
MBCN's Price/Earnings ratio is a bit more expensive when compared to the industry. MBCN is more expensive than 67.51% of the companies in the same industry.
MBCN is valuated rather cheaply when we compare the Price/Earnings ratio to 24.21, which is the current average of the S&P500 Index.
MBCN is valuated correctly with a Price/Forward Earnings ratio of 14.82.
72.54% of the companies in the same industry are cheaper than MBCN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, MBCN is valued a bit cheaper.
Industry RankSector Rank
PE 14.35
Fwd PE 14.82
MBCN Price Earnings VS Forward Price EarningsMBCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MBCN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 14.17
EV/EBITDA N/A
MBCN Per share dataMBCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)13.51
EPS Next 2Y2.13%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

MBCN has a Yearly Dividend Yield of 2.81%. Purely for dividend investing, there may be better candidates out there.
MBCN's Dividend Yield is comparable with the industry average which is at 3.42.
Compared to an average S&P500 Dividend Yield of 2.41, MBCN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

The dividend of MBCN is nicely growing with an annual growth rate of 6.90%!
MBCN has been paying a dividend for at least 10 years, so it has a reliable track record.
MBCN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.9%
Div Incr Years6
Div Non Decr Years17
MBCN Yearly Dividends per shareMBCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

MBCN pays out 41.61% of its income as dividend. This is a bit on the high side, but may be sustainable.
MBCN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP41.61%
EPS Next 2Y2.13%
EPS Next 3YN/A
MBCN Yearly Income VS Free CF VS DividendMBCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MBCN Dividend Payout.MBCN Dividend Payout, showing the Payout Ratio.MBCN Dividend Payout.PayoutRetained Earnings

MIDDLEFIELD BANC CORP

NASDAQ:MBCN (5/9/2025, 8:06:45 PM)

After market: 29.28 0 (0%)

29.28

-0.57 (-1.91%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-16 2025-07-16/bmo
Inst Owners27.08%
Inst Owner Change-0.65%
Ins Owners3.33%
Ins Owner Change0.81%
Market Cap236.58M
Analysts48.89
Price Target28.9 (-1.3%)
Short Float %0.74%
Short Ratio6.85
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend0.8
Dividend Growth(5Y)6.9%
DP41.61%
Div Incr Years6
Div Non Decr Years17
Ex-Date02-28 2025-02-28 (0.21)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.39%
Min EPS beat(2)-11.17%
Max EPS beat(2)27.95%
EPS beat(4)3
Avg EPS beat(4)16%
Min EPS beat(4)-11.17%
Max EPS beat(4)27.95%
EPS beat(8)4
Avg EPS beat(8)4.09%
EPS beat(12)8
Avg EPS beat(12)6.05%
EPS beat(16)12
Avg EPS beat(16)8.73%
Revenue beat(2)0
Avg Revenue beat(2)-1.91%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-2.31%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)-0.04%
Revenue beat(8)1
Avg Revenue beat(8)-2.38%
Revenue beat(12)2
Avg Revenue beat(12)-2.09%
Revenue beat(16)4
Avg Revenue beat(16)-0.91%
PT rev (1m)2.41%
PT rev (3m)-1.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)4.55%
Revenue NY rev (3m)4.55%
Valuation
Industry RankSector Rank
PE 14.35
Fwd PE 14.82
P/S 3.48
P/FCF 14.17
P/OCF 13.54
P/B 1.12
P/tB 1.4
EV/EBITDA N/A
EPS(TTM)2.04
EY6.97%
EPS(NY)1.98
Fwd EY6.75%
FCF(TTM)2.07
FCFY7.06%
OCF(TTM)2.16
OCFY7.38%
SpS8.4
BVpS26.06
TBVpS20.87
PEG (NY)N/A
PEG (5Y)13.51
Profitability
Industry RankSector Rank
ROA 0.84%
ROE 7.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 22.86%
GM N/A
FCFM 24.59%
ROA(3y)0.91%
ROA(5y)0.94%
ROE(3y)7.91%
ROE(5y)8.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.08%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.7
Debt/EBITDA N/A
Cap/Depr 63.04%
Cap/Sales 1.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 107.56%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC14.05%
ROIC/WACCN/A
Cap/Depr(3y)67.12%
Cap/Depr(5y)54.69%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.5%
Profit Quality(3y)113.84%
Profit Quality(5y)117.74%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.12%
EPS 3Y-12.16%
EPS 5Y1.06%
EPS Q2Q%36.36%
EPS Next Y-3.12%
EPS Next 2Y2.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y7.02%
Revenue growth 5Y7.99%
Sales Q2Q%2.89%
Revenue Next Year8.67%
Revenue Next 2Y6.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-21.49%
FCF growth 3Y4.07%
FCF growth 5Y7.62%
OCF growth 1Y-21.86%
OCF growth 3Y4.24%
OCF growth 5Y5.35%